1. Chantot, J. F., Gasc, J. C., Gouin d&Ambrieres, S. ' Lutz, A. (1983). New ether oxime derivatives of erythromycin A: preparation and antibacterial activities. In Program and Abstracts of the Twenty-Third Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 447, p. 165. American Society for Microbiology, Washington, DC.
2. Chantot, J. F., Bryskier, A. & Gasc, J. C. (1986). Antibacterial activity of roxithromycin: a laboratory evaluation. Journal of Antibiotics39, 660–8.
3. Fernandes, P. B., Bailer, R., Swanson, R., Hanson, C. W., McDonald, E., Ramer, N. et al. (1986). In-vitro and in-vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrobial Agents and Chemotherapy30, 865–73.
4. Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright et al. (1987). Spectrum and mode of action of azithromycin (CP-62,993), a new 15 membered ring macrolide with improved potency against Gram-negative organisms. Antimicrobial Agents and Chemotherapy31, 1939–47.
5. Agouridas, C., Bonnefoy, A. & Chantot, J. C. (1995). In vitro antibacterial activity of RU004, a novel ketolide highly active against respiratory pathogens. Program of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA 1995. Abstract F158, 140. American Society for Microbiology, Washington, DC.